Goldline Pharmaceutical Share Price
01 Oct, 2026 4:01 PM (IST)
Goldline Pharmaceutical Performance
- Today's Low
- ₹29
- Today's High
- ₹32
- 52 Week Low
- ₹29
- 52 Week High
- ₹60
- Open Price₹32
- Previous Close₹32
- Volume39,000
- 50 DMA₹37.90
- 100 DMA-
- 200 DMA-
Goldline Pharmaceutical Chart
Investment Returns
- Over 1 Month -24.28%
- Over 3 Month -26.96%
Smart Investing Starts Here Start SIP with Goldline Pharmaceutical for Steady Growth!
Goldline Pharmaceutical Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 7.2
- PEG Ratio
- -
- Market Cap Cr
- 30
- P/B Ratio
- 2.2
- Average True Range
- 2
- EPS
- 4.3
- Dividend Yield
- 0
- MACD Signal
- -2.4
- RSI
- 32.04
- MFI
- 36.73
Latest Stock News Updates
Intimation of Closure of Trading window
- BSE India
- 1 week 3 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar
- BSE India
- 1 month ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar
- BSE India
- 1 month ago
Goldline Pharmaceutical Financials
Goldline Pharmaceutical Technicals
EMA & SMA
- Bearish Moving Average 11
- Bullish Moving Average 0
- 20 Day
- ₹34.50
- 50 Day
- ₹37.90
- 100 Day
- -
- 200 Day
- -
Resistance and Support
- R3 34.80
- R2 33.30
- R1 32.10
- S1 29.40
- S2 27.90
- S3 26.70
Goldline Pharmaceutical Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-06-09 | Audited Results |
About Goldline Pharmaceutical
Goldline Pharmaceutical are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” View More- NSE Symbol
- GLPL
- BSE Symbol
- 544759
- ISIN
- INE1CLW01015
Similar Stocks to Goldline Pharmaceutical
Popular Stocks
Goldline Pharmaceutical FAQs
Goldline Pharmaceutical share price is ₹30 As on 04 October, 2026 | 18:18
The Market Cap of Goldline Pharmaceutical is ₹29.7 Cr As on 04 October, 2026 | 18:18
The P/E ratio of Goldline Pharmaceutical is 7.2 As on 04 October, 2026 | 18:18
The PB ratio of Goldline Pharmaceutical is 2.2 As on 04 October, 2026 | 18:18
The 52 week High & Low of Goldline Pharmaceutical is ₹60/₹28.5 respectively As on 04 October, 2026 | 18:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.